Fungal Presentations

Fungal Presentations from:fungalforum.com

High Dose AmBisome Treatment: what do we know?
By:V-J Anttila, Specialist in Infectious Diseases
Helsinki University Central Hospital, Finland

INVASIVE ASPERGILLOSIS
Management with liposomal amphotericin B
By:Michael Ellis

Is invasive aspergillosis hospital or community acquired: reassessing the evidence?
By:Malcolm Richardson PhD, FIBiol, FRCPath
Department of Bacteriology & Immunology
University of Helsinki, Finland

Invasive fungal infections in immunocompetent patients Does it exists ?

Antifungal combination therapy: where are we?
By:Malcolm Richardson. University of Helsinki.

Emerging fungal pathogens: clinical usefulness of new diagnostic tools

Update on glucan detection
By:Malcolm Richardson PhD, FIBiol, FRCPath
Department of Bacteriology & Immunology
University of Helsinki

Is azole prophylaxis a double-edged sword?
By:Malcolm Richardson PhD, FRCPath
Senior Lecturer in Medical Mycology
University of Helsinki, Finland

Clinical Findings in Rare and Emerging Fungal İnfections
By:Dr. Murat Akova
Hacettepe University School of Medicine
Section of Infectious Diseases
Ankara, Turkey


Liposomal amphotericin B: 20 years of clinical experience
By:Luis Ostrosky-Zeichner, MD, FACP
Assistant Professor of Medicine and Epidemiology
University of Texas Health Science Center at Houston

Antifungal and Surgical Management of a Case of Maxillary Sinus Aspergilloma
By:Riina Rautemaa
DDS, PhD, Consultant of Oral Microbiology
Helsinki University Central Hospital Maxillofacial Clinic and Laboratory Diagnostics;
and Haartman Institute, University of Helsinki, Finland


AMPHOTERICIN B NEPHROTOXICITY
By:GILBERT DERAY
PARIS , FRANCE

Changing Epidemiology:
The Importance of Broad Spectrum Therapeutics
By:Cornelia Lass-Flörl
Innsbruck Medical University

Antifungal treatment: Past and Present
By:Malcolm Richardson, PhD, FIBiol, FRCPath
University of Helsinki

Is combination antifungal therapy a viable option for the future?
By: Brian L Jones
Glasgow Royal Infirmary, UK

Fungal infections in solid organ transplantation recipients
By:Malcolm Richardson PhD, FIBiol, FRCPath
University of Helsinki and Helsinki University Central Hospital

Ten years experience of liposomal amphotericin B, AmBisome treatment in solid organ transplant recipients (SOT)

Advances in Empirical Antifungal Therapy in Patients with Febrile Neutropenia.
By:Marc A. Boogaerts

Does azole prophylaxis confer resistance to amphotericin B and influence virulence?
By:Malcolm Richardson
Department of Bacteriology & Immunology Haartman Institute
University of Helsinki

Liposomal amphotericin B: 20 years of clinical experience
The body of knowledge and familiarity of use
By:Malcolm Richardson PhD, FIBiol, FRCPath
Associate Professor in Medical Mycology
University of Helsinki, Finland

Prophylaxis of invasive fungal infections in high risk patients with hematologic malignancies
By:Olaf Penack